Risedronate shown to be safe and effective in men with osteoporosis in a 2-year, double-blind, randomized, placebo-controlled, multicenter study

被引：0
|
作者：
Boonen, S.
Delmas, P. D.
Wenderoth, D.
Stoner, K. J.
Eusebio, R.
Orwoll, E. S.
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] INSERM, Res Unit 403, F-69008 Lyon, France
[3] Procter & Gamble Pharmaceut, Schwalbach, Germany
[4] Procter & Gamble Pharmaceut, Mason, OH USA
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S230 / S231
页数：2
相关论文
共 50 条
  • [21] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [22] A randomized, double-blind, placebo-controlled study of once weekly elcatonin in primary postmenopausal osteoporosis
    Sugimoto, Toshitsugu
    Shiraki, Masataka
    Nakano, Tetsuo
    Kishimoto, Hideaki
    Ito, Masako
    Fukunaga, Masao
    Sone, Teruki
    Hagino, Hiroshi
    Miki, Takami
    Nishizawa, Yoshiki
    Akachi, Shinobu
    Nakamura, Toshitaka
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (03) : 447 - 454
  • [23] Effect of udenafil administration on postmicturition dribbling in men: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical study
    Ko, Kyungtae
    Lee, Won Ki
    Cho, Sung Tae
    Lee, Young Gu
    Shin, Tae Young
    Choo, Min Soo
    Han, Jun Hyun
    Lee, Seong Ho
    Oh, Cheol Young
    Cho, Jin Seon
    Jeong, Hyun Cheol
    Yang, Dae Yul
    AGING MALE, 2020, 23 (05): : 571 - 578
  • [24] Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study
    Ran, S. Y.
    Yu, Q.
    Chen, Y.
    Lin, S. Q.
    CLIMACTERIC, 2017, 20 (04) : 391 - 396
  • [25] A 2-year, multicenter, placebo-controlled, double-blind, parallel-group study of the effect of riluzole on Parkinson's disease progression
    Rascol, O
    Olanow, W
    Brooks, D
    Koch, G
    Truffinet, P
    Bejuit, R
    MOVEMENT DISORDERS, 2002, 17 : S39 - S39
  • [26] Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial
    Arnold, Lesley M.
    Goldenberg, Don L.
    Stanford, Sharon B.
    Lalonde, Justine K.
    Sandhu, H. S.
    Keck, Paul E., Jr.
    Welge, Jeffrey A.
    Bishop, Fred
    Stanford, Kevin E.
    Hess, Evelyn V.
    Hudson, James I.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1336 - 1344
  • [27] OATS IN THE DIET OF CHILDREN WITH CELIAC DISEASE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY
    Lionetti, E.
    Gatti, S.
    Caporelli, N.
    Galeazzi, T.
    Francavilla, R.
    Barbato, M.
    Roggero, P.
    Malamisura, B.
    Iacono, G.
    Tomarchio, S.
    Budelli, A.
    Gesuita, R.
    Catassi, C.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E248 - E248
  • [28] Bosentan therapy in patients with Eisenmenger syndrome - A multicenter, double-blind, randomized, placebo-controlled study
    Galie, Nazzareno
    Beghetti, Maurice
    Gatzoulis, Michael A.
    Granton, John
    Berger, Rolf M. F.
    Lauer, Andrea
    Chiossi, Eleonora
    Landzberg, Michael
    CIRCULATION, 2006, 114 (01) : 48 - 54
  • [29] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [30] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
12345